Kenneth Williams

Dr. Kenneth Williams is a Professor (Adjunct) of Research in Molecular Biophysics and Biochemistry at Yale University, affiliated with the Yale School of Medicine. He is the Founder of the W.M. Keck Foundation Biotechnology Resource Laboratory and Co-Director of the Yale/NIDA Neuroproteomics Center. His research focuses on proteomics, mass spectrometry technologies, and biomarker discovery for diseases like cancer and addiction. Williams earned his B.S. in Chemistry from Boston University (1971) and his Ph.D. in Biochemistry from the University of Vermont (1976). He completed postdoctoral training at Yale in Molecular Biophysics and Biochemistry. His work includes developing targeted proteomic assays for kidney transplant recovery and ovarian cancer diagnostics, leveraging advanced mass spectrometry techniques. He has held leadership roles in organizations like the Association of Biomolecular Resource Facilities (ABRF) and secured major NIH grants for proteomics initiatives.

• Education:
• B.S., Chemistry, Boston University, 1971
• Ph.D., Biochemistry, University of Vermont, 1976
• Key Research Areas:
• Neuroproteomics and addiction mechanisms
• Proteomic biomarkers for kidney and ovarian diseases
• High-throughput proteomics technologies
• Affiliations:
• Yale/NIDA Neuroproteomics Center (Co-Director since 2015)
• Keck Biotechnology Resource Laboratory (Founder since 1980)
• Grants & Recognition:
• NIH/NIDA Neuroproteomics Center funding (since 2004)
• ABRF Executive Board member (1988–present)

His research integrates proteomics with clinical applications, emphasizing translational medicine and technological innovation. Collaborators include experts in neuroscience, oncology, and bioinformatics. Current projects explore single-cell proteomics and biomarker validation for early disease detection.